Guatemala: HIV patients protest new trade laws urged by USA that restrict access to generic medicines - Bristol-Myers Squibb says patent protections needed to fuel innovation

Get RSS feed of these results

All components of this story

Company response
12 April 2005

Bristol-Myers Squibb statement on access to medicines

Author: Bristol-Myers Squibb

Bristol-Myers Squibb is focused on broadening access to all of our medications throughout the world...We have worked with governments around the world to expand access to medications and price them appropriately.

🚫Read the full post here

Article
30 March 2005

Guatemalan HIV patients slam new trade rules

Author: Frank Jack Daniel, Reuters

Dozens of Guatemalan HIV patients, many with paper bags over their heads to protect their identities, protested on Wednesday at new U.S.-backed trade rules they say rob them of access to medicines...Pharmaceutical companies like Bristol-Myers Squibb, which makes an HIV medicine protected in Guatemala under the new rules, say the changes are needed to protect innovation.

🚫Read the full post here

Article
1 February 2005

Data Exclusivity & Access to Medicines in Guatemala

Author: Doctors Without Borders/Médecins Sans Frontières

...generic competition [in Guatemala and elsewhere] has been effective in bringing down prices...[and] making life-extending treatment available...this access is now being threatened...[by “free trade agreements” with the USA] that limit generic competition and the ability of countries...to protect public health and ensure access to medicines...Treating fewer people means condemning others to premature death. [refers to GlaxoSmithKline, Bristol-Myers Squibb]

Read the full post here